>
>
Therapeutic Advances in Respiratory Disease

Therapeutic Advances in Respiratory Disease

呼吸系统疾病的治疗进展
THER ADV RESPIR DIS
影响因子：3
JCR分区：Q2
新锐分区：医学3区
是否综述期刊：N/A
是否预警：不在预警名单内
是否OA：是
出版国家/地区：ENGLAND
出版社：SAGE Publications Ltd
发刊时间：0
收录数据库：SCIE/Scopus收录/DOAJ开放期刊
ISSN：1753-4658

期刊介绍

Therapeutic Advances in Respiratory Disease delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of respiratory disease.
《呼吸系统疾病的治疗进展》提供了最高质量的同行评审文章、综述和学术评论，涉及呼吸系统疾病所有领域的开创性努力和创新研究。
年发文量 93
国人发稿量 15.81
国人发文占比 0.17%
自引率 3.3%
平均录取率-
平均审稿周期 15 Weeks
版面费 USD2650
偏重研究方向 RESPIRATORY SYSTEM-
期刊官网 https://uk.sagepub.com/en-gb/chi/journal/therapeutic-advances-respiratory-disease
投稿链接 https://mc.manuscriptcentral.com/tar

期刊高被引文献

The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619844424
Triple therapy for COPD: a crude analysis from a systematic review of the evidence
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619885522
Association between tumor necrosis factor-α and chronic obstructive pulmonary disease: a systematic review and meta-analysis
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619866096
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619831906
Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619866097
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619841274
Safety of tiotropium in patients with asthma
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466618824010
DT-0111: a novel drug-candidate for the treatment of COPD and chronic cough
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619877960
Preclinical and clinical studies of smoke-inhalation-induced acute lung injury: update on both pathogenesis and innovative therapy
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619847901
Fiducial marker placement with electromagnetic navigation bronchoscopy: a subgroup analysis of the prospective, multicenter NAVIGATE study
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619841234
What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619884532
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619847130
Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619866102
Contemporary optimized practice in the management of pulmonary sarcoidosis
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619868935
Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619891529
Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619885530
Bronchopulmonary dysplasia: what are its links to COPD?
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619892492
Long-term follow up after endoscopic valve therapy in patients with severe emphysema
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619866101
Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619875925
Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466618823440
Cardiovascular morbidities of obstructive sleep apnea and the role of circulating extracellular vesicles
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619895229
Practical management of riociguat in patients with pulmonary arterial hypertension
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619868938
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β2-agonist fixed-dose combinations in COPD
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619894502
The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619853500
Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619841350
Tailored combined cytomegalovirus management in lung transplantation: a retrospective analysis
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619878555
Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619888127
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619888128
The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619860058
Duration of treatment with inhaled corticosteroids in nonasthmatic eosinophilic bronchitis: a randomized open label trial
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619891520
Characteristics and outcome of patients set up on high-flow oxygen therapy at home
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619879794
Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619885529
Noninvasive ventilation failure in patients with hypoxemic respiratory failure: the role of sepsis and septic shock
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619888124
lloprost delivered via the BREELIBTM nebulizer: a review of the clinical evidence for efficacy and safety
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619835497
Global transcriptional regulation of STAT3- and MYC-mediated sepsis-induced ARDS
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619879840
Clinical outcomes of chemical pleurodesis using a minocycline
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619841231
Prognosis of combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis alone
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619888119
The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619843426
Single application of airway stents in thoracogastric-airway fistula: results and prognostic factors for its healing
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619871523
Duration of sweep gas off trial for weaning from venovenous extracorporeal membrane oxygenation
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619888131
Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) versus low PEEP on patients with moderate–severe acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619858228
Appropriate treatment sessions of flexible bronchoscopic balloon dilation for patients with nonmalignant central airway stenosis
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619831966
How prolonged mechanical ventilation is a neglected disease in chest medicine: a study of prolonged mechanical ventilation based on 6 years of experience in Taiwan
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619878552
Medication persistence rates and predictive factors for discontinuation of antifibrotic agents in patients with idiopathic pulmonary fibrosis: a real-world observational study
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619872890
Chronic progressive pulmonary paracoccidioidomycosis in a female immigrant from Venezuela
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619894913
Extended anticoagulation after venous thromboembolism: should it be done?
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619878556
Early corticosteroid treatment for postoperative acute lung injury after lung cancer surgery
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619840256
High immunoglobulin E level is associated with increased readmission in children with bronchopneumonia
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619879832
Baseline history of patients using selexipag for pulmonary arterial hypertension
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619843774
Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities
来源期刊：Therapeutic Advances in Respiratory DiseaseDOI：10.1177/1753466619880076

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
83.87%99.15%--

相关指数

影响因子
影响因子
年发文量
自引率

预警情况

查看说明
时间 预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源：中科院《 国际期刊预警名单》

JCR分区

WOS分区等级：2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方（Web of Science）为每个学科内的期刊按照IF数值排 序，将期刊按照四等分的方法划分的Q1-Q4等级，Q1代表质量最高，即常说的1区期刊。
（2024-2025年最新版）
RESPIRATORY SYSTEM
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2026年3月发布
(新锐分区)
医学3区
RESPIRATORY SYSTEM 呼吸系统
3区
否
N/A
2025年3月升级版
医学3区
RESPIRATORY SYSTEM 呼吸系统
3区
否
否
2023年12月旧的升级版
医学3区
RESPIRATORY SYSTEM 呼吸系统
4区
否
否

CiteScore

查看说明
CiteScore SJR SNIP 学科 分区 排名
4.70
0.970
0.934
大类：Medicine 小类：Pulmonary and Respiratory Medicine
大类：Medicine 小类：Pharmacology (medical)
Q2
Q2
58 / 159
109 / 275

相关文章

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY：影响因子从1.2跃升至2.0，这本眼整形修复期刊如何在眼眶的方寸之间守护患者的视功能与尊严？
2026-06-23
那些"阳不起来"的药理数据，为什么新西兰这本OA刊（Drugs in R&D，IF=2.1，Q3药理）愿意接：研发中药物的另类归宿
2026-06-23
Indian Journal of Medical Microbiology：年发文150+、非OA零费用，医学微生物学领域一本高性价比的Q4期刊
2026-06-23
JOURNAL OF SCHOOL HEALTH：美国老牌期刊，1.8分JCR Q2，零版面费，国人友好
2026-06-23
Critical Care Nurse：44 年铸就重症护理标杆，重塑全球 ICU 临床实践标准
2026-06-23
HEALTH PROMOTION INTERNATIONAL：影响因子2.7、自引率20.8%，这本健康促进旗舰期刊为何在争议中引领学科前沿？
2026-06-23
PEDIATRIC CLINICS OF NORTH AMERICA：创刊 70 年的儿科临床专题式综述旗舰
2026-06-23
Journal of Community Health Nursing：影响因子1.0、自引率0%，这本社区护理期刊如何在医院之外守护公众健康？
2026-06-23
当动脉粥样硬化的战场从"降脂达标"走向"残余风险"：Current Atherosclerosis Reports（IF=5.2，Q1心血管，医学2区）为什么更像一份"专家共识型雷达"，而不是灌水通道
2026-06-23
MEDICAL CLINICS OF NORTH AMERICA：JCR Q1、零版面费，内科综述领域一本百年老刊的投稿价值
2026-06-23